An Interview with Sergey Young of the Longevity Vision Fund

The Longevity Vision Fund is the third of the sizable pools of venture funding to emerge of late, after Juvenescence and Life Biosciences, that are dedicated to the new longevity industry. Unlike the other two, the Longevity Vision fund is initially focused on what I would say are initiatives that don't much matter and won't much move the needle on human aging. Only in their second phase do they intend to invest in classes of biotechnology and therapy that may include high value approaches. Despite the way in which senolytics to remove harmful senescent cells outperform everything else to date in reversal of aging and age-related disease, we are still, it seems, somewhat early in the phase of spreading the understanding that repair based strategies are the only real way forward to sizable gains in human health and life span in old age. Aging is damage and repair of that damage is rejuvenation - as a steering principle, this is still not yet widely adopted. As a result a great deal of funding is going to be used on projects that do very little of consequence in the matter of aging. At a conference not so long ago, I mentioned this to a wealth manager, who shrugged and said that there is so much potential funding on the sidelines, tipping towards becoming involved, that it doesn't much matter - just fund everything with a credible team and let the chips fall where they may. There so many things that make longevity investment risky. Not only is it subject to all ...
Source: Fight Aging! - Category: Research Authors: Tags: Daily News Source Type: blogs